Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]

PSA/Prostate screening

Dr. Otis W. Brawley - Chief Medical Officer, ASCO

PSA/Prostate screening ( Dr. Otis W. Brawley - Chief Medical Officer, ASCO )

Cancer prevention strategies

Professor Peter Boyle, International Prevention Research Institute

Cancer prevention strategies ( Professor Peter Boyle, International Prevention Research Institute )

Zoledronic acid for treament of prostate cancer

Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals

Zoledronic acid for treament of prostate cancer ( Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals )

ASCO: Patient accrual in clinical trials

Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA

ASCO: Patient accrual in clinical trials ( Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA )

ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash

Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash ( Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA )

ASCO: Impact of common antidepressants on tamoxifen effectiveness

Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The...

ASCO: Impact of common antidepressants on tamoxifen effectiveness ( Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherlands )

ASCO: Oxaliplatin does not improve outcomes for rectal cancer

Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy

ASCO: Oxaliplatin does not improve outcomes for rectal cancer ( Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy )

ASCO: Pemetrexed extends survival as maintenance therapy

Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA

ASCO: Pemetrexed extends survival as maintenance therapy ( Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA )

ASCO: Trial compares common adjuvant treatments for pancreatic cancer

Dr. John Neoptolemos - University of Liverpool, Liverpool, UK

ASCO: Trial compares common adjuvant treatments for pancreatic cancer ( Dr. John Neoptolemos - University of Liverpool, Liverpool, UK )

ASCO: Surgery unnecessary for majority of patients with advanced colorectal...

Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA

ASCO: Surgery unnecessary for majority of patients with advanced colorectal cancer ( Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA )

ASCO: Lung cancer screening by low-dose computed tomography results in high...

Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland...

ASCO: Lung cancer screening by low-dose computed tomography results in high rate of false positives ( Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland, USA )

ASCO: Low rates of screening among childhood cancer survivors

Dr. Paul Nathan - Hospital for Sick Children, Toronto, Canada

ASCO: Low rates of screening among childhood cancer survivors ( Dr. Paul Nathan - Hospital for Sick Children, Toronto, Canada )

More from ecancer